Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Mark M. Dermot DurcanIndependent Chairman of the Board | 4,00k | 1,07M | Kauf | 266,26 | 26,86k | 17,50% |
| 2026-03-11 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 4,74k | 0,00 | Derivative Exercise and Retained Stock | - | 23,57k | 25,19% |
| 2026-03-11 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -3,67k | 1,29M | Derivative Exercise and Sale | 350,30 | 23,57k | - |
| 2026-03-11 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 6,78k | 0,00 | Derivative Exercise and Retained Stock | - | 30,71k | 28,34% |
| 2026-03-11 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -5,84k | 2,05M | Derivative Exercise and Sale | 350,30 | 30,71k | - |
| 2026-03-11 | Mr. James F. ClearyExec. VP & CFO | 7,21k | 0,00 | Derivative Exercise and Retained Stock | - | 160,36k | 4,71% |
| 2026-03-11 | Mr. James F. ClearyExec. VP & CFO | -5,41k | 1,89M | Derivative Exercise and Sale | 350,30 | 160,36k | - |
| 2026-02-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,03M | Derivative Exercise and Sale | 86,09 - 358,94 | 65,39k | - |
| 2026-02-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 479,16k | Verkauf | 359,46 | 65,39k | -2,00% |
| 2026-01-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,01M | Derivative Exercise and Sale | 86,09 - 354,73 | 66,73k | - |
| 2026-01-20 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 472,86k | Verkauf | 354,73 | 66,73k | -1,96% |
| 2025-12-19 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -1,68k | 578,57k | Verkauf | 345,00 | 18,80k | -8,19% |
| 2025-12-19 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -3,35k | 1,15M | Verkauf | 342,10 | 23,89k | -12,30% |
| 2025-12-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 968,45k | Derivative Exercise and Sale | 86,09 - 343,45 | 68,06k | - |
| 2025-12-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 457,82k | Verkauf | 343,45 | 68,06k | -1,92% |
| 2025-12-17 | Dr. Robert P. MauchPresident, CEO & Director | -3,00k | 0,00 | Other Disposition | - | 66,39k | -4,32% |
| 2025-12-17 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -4,03k | 1,38M | Verkauf | 343,24 | 17,15k | -19,03% |
| 2025-12-17 | Mr. James F. ClearyExec. VP & CFO | 18,20k | 1,57M | Derivative Exercise and Retained Stock | 86,09 | 153,14k | 13,49% |
| 2025-12-17 | Mr. James F. ClearyExec. VP & CFO | -26,95k | 6,96M | Derivative Exercise and Sale | 86,09 - 344,15 | 153,14k | - |
| 2025-12-17 | Mr. Dennis M. NallyIndependent Director | -1,17k | 0,00 | Other Disposition | - | 11,52k | -9,24% |
| 2025-12-15 | Dr. Robert P. MauchPresident, CEO & Director | -638,00 | 223,50k | Derivative Exercise and Sale | 350,32 | 69,39k | - |
| 2025-12-15 | Mr. James F. ClearyExec. VP & CFO | -199,00 | 69,71k | Derivative Exercise and Sale | 350,32 | 134,94k | - |
| 2025-12-15 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -91,00 | 31,88k | Derivative Exercise and Sale | 350,32 | 21,19k | - |
| 2025-11-20 | Dr. Robert P. MauchPresident, CEO & Director | 3,65k | 0,00 | Derivative Exercise and Retained Stock | - | 69,39k | 5,55% |
| 2025-11-20 | Dr. Robert P. MauchPresident, CEO & Director | -2,14k | 776,28k | Derivative Exercise and Sale | 362,07 | 69,39k | - |
| 2025-11-20 | Mr. James F. ClearyExec. VP & CFO | 1,05k | 0,00 | Derivative Exercise and Retained Stock | - | 134,94k | 0,79% |
| 2025-11-20 | Mr. James F. ClearyExec. VP & CFO | -824,00 | 298,35k | Derivative Exercise and Sale | 362,07 | 134,94k | - |
| 2025-11-20 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 854,00 | 0,00 | Derivative Exercise and Retained Stock | - | 27,24k | 3,24% |
| 2025-11-20 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -736,00 | 266,48k | Derivative Exercise and Sale | 362,07 | 27,24k | - |
| 2025-11-20 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | 602,00 | 0,00 | Derivative Exercise and Retained Stock | - | 21,19k | 2,92% |
| 2025-11-20 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -421,00 | 152,43k | Derivative Exercise and Sale | 362,07 | 21,19k | - |
| 2025-11-20 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | 964,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,15k | 23,04% |
| 2025-11-20 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | -1,01k | 365,69k | Derivative Exercise and Sale | 362,07 | 5,15k | - |
| 2025-11-20 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 526,00 | 0,00 | Derivative Exercise and Retained Stock | - | 20,47k | 2,64% |
| 2025-11-20 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -406,00 | 147,00k | Derivative Exercise and Sale | 362,07 | 20,47k | - |
| 2025-11-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 1,06M | Derivative Exercise and Sale | 86,09 - 366,64 | 65,75k | - |
| 2025-11-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 488,73k | Automatic Disposition | 366,64 | 65,75k | -1,99% |
| 2025-11-13 | Dr. Robert P. MauchPresident, CEO & Director | -18,68k | 5,84M | Sale to Issuer | 312,53 | 67,08k | -21,78% |
| 2025-11-13 | Mr. James F. ClearyExec. VP & CFO | -13,90k | 4,34M | Sale to Issuer | 312,53 | 133,89k | -9,41% |
| 2025-11-13 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -9,53k | 2,98M | Sale to Issuer | 312,53 | 26,39k | -26,54% |
| 2025-11-13 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -1,06k | 330,97k | Sale to Issuer | 312,53 | 20,58k | -4,89% |
| 2025-11-13 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -5,61k | 1,75M | Sale to Issuer | 312,53 | 19,95k | -21,96% |
| 2025-11-07 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | 1,33k | 0,00 | Derivative Exercise and Retained Stock | - | 12,67k | 11,68% |
| 2025-11-07 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -1,02k | 369,36k | Derivative Exercise and Sale | 360,70 | 12,67k | - |
| 2025-11-07 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 15,31k | 19,36% |
| 2025-11-07 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -1,37k | 494,16k | Derivative Exercise and Sale | 360,70 | 15,31k | - |
| 2025-11-07 | Mr. James F. ClearyExec. VP & CFO | 3,44k | 0,00 | Derivative Exercise and Retained Stock | - | 117,73k | 3,01% |
| 2025-11-07 | Mr. James F. ClearyExec. VP & CFO | -1,96k | 705,17k | Derivative Exercise and Sale | 360,70 | 117,73k | - |
| 2025-11-07 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | 2,05k | 0,00 | Derivative Exercise and Retained Stock | - | 19,21k | 11,97% |
| 2025-11-07 | Mr. Lazarus KrikorianSenior VP, CAO & Corporate Controller | -777,00 | 280,26k | Derivative Exercise and Sale | 360,70 | 19,21k | - |
| 2025-11-07 | Dr. Robert P. MauchPresident, CEO & Director | 4,87k | 0,00 | Derivative Exercise and Retained Stock | - | 42,81k | 12,84% |
| 2025-11-07 | Dr. Robert P. MauchPresident, CEO & Director | -3,41k | 1,23M | Derivative Exercise and Sale | 360,70 | 42,81k | - |
| 2025-10-31 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | 4,17k | 1,41M | Derivative Exercise and Retained Stock | 337,81 | 4,18k | 29.785,71% |
| 2025-10-31 | Mr. Pawan Singh VermaExec. VP and Chief Data & Information Officer | -4,37k | 0,00 | Derivative Exercise and Sale | 337,81 | 4,18k | - |
| 2025-10-20 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 905,79k | Derivative Exercise and Sale | 86,09 - 326,80 | 37,94k | - |
| 2025-10-20 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 435,95k | Automatic Disposition | 326,80 | 37,94k | -3,40% |
| 2025-10-01 | Ms. Elizabeth S. CampbellExec. VP & Chief Legal Officer | -1,89k | 590,85k | Automatic Disposition | 313,28 | 12,82k | -12,82% |
| 2025-09-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,76k | 767,31k | Derivative Exercise and Sale | 86,09 - 290,00 | 39,27k | - |
| 2025-09-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,33k | 386,86k | Automatic Disposition | 290,00 | 39,27k | -3,29% |
| 2025-09-16 | Mr. Steven H. CollisInsider | -29,35k | 5,98M | Derivative Exercise and Sale | 86,09 - 289,86 | 305,91k | - |
| 2025-09-16 | Mr. Steven H. CollisInsider | -2,00k | 579,72k | Automatic Disposition | 289,86 | 305,91k | -0,65% |
| 2025-08-19 | Mr. Steven H. CollisInsider | -12,58k | 2,56M | Derivative Exercise and Sale | 86,09 - 289,98 | 307,91k | - |
| 2025-08-19 | Mr. Steven H. CollisInsider | -2,00k | 579,96k | Automatic Disposition | 289,98 | 307,91k | -0,65% |
| 2025-08-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 668,99k | Derivative Exercise and Sale | 86,09 - 293,53 | 40,61k | - |
| 2025-08-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 511,62k | Automatic Disposition | 293,53 | 40,61k | -4,12% |
| 2025-07-22 | Mr. Steven H. CollisInsider | -12,58k | 2,60M | Derivative Exercise and Sale | 86,09 - 292,67 | 309,91k | - |
| 2025-07-22 | Mr. Steven H. CollisInsider | -2,00k | 585,34k | Automatic Disposition | 292,67 | 309,91k | -0,64% |
| 2025-07-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 670,86k | Derivative Exercise and Sale | 86,09 - 294,11 | 42,35k | - |
| 2025-07-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 512,63k | Automatic Disposition | 294,11 | 42,35k | -3,95% |
| 2025-06-24 | Mr. Steven H. CollisInsider | -12,58k | 2,60M | Derivative Exercise and Sale | 86,09 - 292,62 | 311,91k | - |
| 2025-06-24 | Mr. Steven H. CollisInsider | -2,00k | 585,24k | Automatic Disposition | 292,62 | 311,91k | -0,64% |
| 2025-06-18 | Ms. Silvana BattagliaExec. VP & Chief HR Officer | -4,08k | 1,21M | Verkauf | 297,41 | 11,30k | -26,52% |
| 2025-06-18 | Dr. Robert P. MauchPresident, CEO & Director | -3,23k | 674,70k | Derivative Exercise and Sale | 86,09 - 295,30 | 44,09k | - |
| 2025-06-18 | Dr. Robert P. MauchPresident, CEO & Director | -1,74k | 515,00k | Automatic Disposition | 295,30 | 44,09k | -3,80% |
| 2025-06-02 | Walgreens Holding CompanyUnternehmen | -765,00k | 0,00 | Verkauf | - | 9,62M | -7,37% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
